Showing results (61-70 of 679) with videos related to
Sort By:
Pageof 68
American Journal of Clinical Dermatology|June 10, 2004
Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current viewAnita Ruetter, Thomas A LugerDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 16, 2004
[Alpha-melanocyte-stimulating hormone. Its current significance for dermatology]M Böhm, T A LugerJournal of Cutaneous Pathology|December 1, 1996
Ultrastructural localization of carcinoembryonic antigen (CEA) glycoproteins and epithelial membrane antigen (EMA) in normal and neoplastic sweat glandsD Metze, T A LugerJournal of the American Academy of Dermatology|June 1, 1991
Therapeutic use of cytokines in dermatologyT A Luger, T SchwarzClinical and Experimental Dermatology|December 5, 2002
Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseasesU Frieling, T A LugerZeitschrift Fur Hautkrankheiten|January 1, 1984
[Immunomodulation using an epidermal cytokine (ETAF)]T A Luger, G NiebauerThe Journal of Biological Chemistry|April 5, 1989
Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulinW Borth, T A LugerDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 2010
[Alpha-melanocyte-stimulating hormone. From bench to bedside]M Böhm, T A LugerCurrent Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseasesAnita Rütter, Thomas A LugerJournal of the American Academy of Dermatology|May 23, 2001
High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skinA Rütter, T A LugerPageof 68